Year: 2024
Type: article
Abstract: Type 1 diabetes (TID) is an organ-specific autoimmune disease in which the selective destruction of islet B cells mediated by the T lymphocytes leads to absolute insulin deficiency, especially result from the interaction between genetic and non-genetic factors which is prevalent among teenagers all over the world. However, there also a lot of challenge in clinical and the trigger of the T1D.This essay comprehensively review the currently study of etiology, epidemiology, and management of T1D. he essay mainly aim at understanding the theory of disease as the result of improve in the therapeutic schedule. Moreover, recent innovation in immunotherapy especially in specific islet immune pathways and innovations in non-invasive blood glucose monitoring technologies make the therapy for the patient more efficient and more. At the same time, it is hoped that there will be more relevant studies in the future to continuously improve the understanding of its heterogeneity and prognostic markers, and improve and develop treatment strategies and management methods, so as to benefit patients.
DOI: 10.54097/t2vyt237
Author: Jiawen Xu
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W4405810898